New drug trial offers hope for Tough-to-Treat eczema
Disease control
Recruiting now
This study is testing a new drug called IMG-007 to see if it can reduce the severity of eczema and is safe for adults with moderate-to-severe cases. It will compare different doses of the drug against a placebo (an inactive substance) in about 220 people over 52 weeks. The goal i…
Phase: PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC